Company profile
saverna therapeutics AG
Gewerbestrasse 24
3dr Floor
4123 Allschwil
Switzerland
3dr Floor
4123 Allschwil
Switzerland
Small molecules at pre-clinical stage
Targeting RNA
Candidate Drugs for Lupus and Scleroderma
Biotech
Saverna Therapeutics is an early stage pharmaceutical start-up founded with the vision to develop small molecule drugs that target non-coding RNA for the treatment of diseases with high unmet need. We have identified drug-like small molecules that can be beneficial for patients with Lupus or Scleroderma diseases. The company is seeking an investment of CHF 3 millions to advance one molecule candidate to pre-IND stage.
Contact
